Clinical Trial Results:
A multi-center, randomized, open-label study in patients with COVID-19 and respiratory distress not requiring mechanical ventilation, to compare standard-of-care with anakinra and tocilizumab treatment.
The Immunomodulation-CoV Assessment (ImmCoVA) study.
Summary
|
|
EudraCT number |
2020-001748-24 |
Trial protocol |
SE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Mar 2023
|
First version publication date |
11 Mar 2023
|
Other versions |
|
Summary report(s) |
Manuscript Supplements |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.